These latter results appear to contradict those reporting the downregulation of CD1a+ DC gene in relation to BC patients achieving pCR after NAC [66], but were in line with authors associating the presence of high CD1a+ counts with longer progression free-survival than patients with lesions with a low level of infiltration [67]. The gene discussed is CD1A; the disease is breast cancer.